Literature DB >> 15969501

Oviposition responses of culex pipiens to a synthetic racemic Culex quinquefasciatus oviposition aggregation pheromone.

Antonios Michaelakis1, Anastasia P Mihou, Elias A Couladouros, Athanasios K Zounos, George Koliopoulos.   

Abstract

The oviposition pheromone of Culex quinquefasciatus was synthesized in a racemic form in a simple (five steps), efficient, high yielding (45% total yield), and low cost way (use of relatively low cost reagents). Our synthetic racemic pheromone (SRP) was tested in the laboratory for its bioactivity on Culex pipiens biotype molestus, which is a member of the species complex that Culex quinquefasciatusbelongs. In the testing conditions, bioactivity at the doses of 0.01, 0.1, 1, and 10 microg per cage was found with the best bioactivity achieved at 1 mug per cage. The effectiveness of our SRP offers a capable tool for improving mosquito oviposition traps for surveillance or even control programs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15969501     DOI: 10.1021/jf0504871

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  3 in total

1.  Oviposition responses of gravid female Culex quinquefasciatus to egg rafts and low doses of oviposition pheromone under semifield conditions.

Authors:  Marieta A Braks; Walter S Leal; Ring T Cardé
Journal:  J Chem Ecol       Date:  2007-03       Impact factor: 2.626

2.  Influence of the microencapsulated pheromone from aged infusion as an oviposition medium of the West Nile virus vector Culex pipiens.

Authors:  Antonios Michaelakis; Anastasia P Mihou; George Koliopoulos; Elias A Couladouros
Journal:  Parasitol Res       Date:  2008-11-26       Impact factor: 2.289

3.  Larvicidal activity of naturally occurring naphthoquinones and derivatives against the West Nile virus vector Culex pipiens.

Authors:  Antonios Michaelakis; Alexandros T Strongilos; Emmanuel A Bouzas; George Koliopoulos; Elias A Couladouros
Journal:  Parasitol Res       Date:  2008-11-08       Impact factor: 2.289

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.